부산대학교 도서관

Carbone, Cristina; Dinelli, Enrico; De Waele, Jo

INTERNATIONAL JOURNAL OF SPELEOLOGY; MAY 2016, 45 2, p171-p183, 13p.

De Waele, Jo; Mucedda, Mauro; Montanaro, Luca

Geomorphology. May2009, Vol. 106 Issue 1/2, p26-34. 9p.

Bontognali, Tomaso R. R.; D'Angeli, Ilenia M.; Tisato, Nicola; Vasconcelos, Crisogono; Bernasconi, Stefano M.; Gonzales, Esteban R. G.; De Waele, Jo

FRONTIERS IN EARTH SCIENCE; APR 28 2016, 4 pUNSP 49 8p.

Environmental Geology; Jul2009, Vol. 58 Issue 2, p239-255, 17p, 3 Black and White Photographs, 1 Diagram, 6 Charts, 1 Map

Margalit I; Infectious Diseases Unit, Sheba Medical Center, Ramat-Gan, Israel. ilimargalit@gmail.com.; Faculty of Medical & Health Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel. ilimargalit@gmail.com.; Yahav D; Infectious Diseases Unit, Sheba Medical Center, Ramat-Gan, Israel.; Faculty of Medical & Health Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.; Hoffman T; Infectious Diseases Unit, Sheba Medical Center, Ramat-Gan, Israel.; Faculty of Medical & Health Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.; Tabah A; Intensive Care Unit, Redclife Hospital, Brisbane, QLD, Australia.; Queensland University of Technology, Brisbane, QLD, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.; Ruckly S; IAME UMR 1137, INSERM, Université de Paris, 75018, Paris, France.; ICUREsearch, Biometry, 38600, Fontaine, France.; Barbier F; Service de Médecine Intensive‑Réanimation, Centre Hospitalier Régional d'Orléans, 14, Avenue de L'Hôpital, 45100, Orléans, France.; Singer P; Faculty of Medical & Health Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.; Department of General Intensive Care and Institute for Nutrition Research, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.; Timsit JF; IAME UMR 1137, INSERM, Université de Paris, 75018, Paris, France.; Medical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat-Claude Bernard University Hospital, 46 Omdurman Maternity Hospital Rue Henri Huchard, 75877, Paris, France.; Prendki V; Division of Internal Medicine for the Aged, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.; Infection Control Programme and World Health Organization Collaborating Center, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.; Buetti N; IAME UMR 1137, INSERM, Université de Paris, 75018, Paris, France.; Infection Control Programme and World Health Organization Collaborating Center, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

Publisher: Springer Heidelberg Country of Publication: Germany NLM ID: 0365307 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-0973 (Electronic) Linking ISSN: 03008126 NLM ISO Abbreviation: Infection Subsets: MEDLINE

De Waele, Jo; Plan, Lukas; Audra, Philippe

Geomorphology. May2009, Vol. 106 Issue 1/2, p1-8. 8p.

Tisato, Nicola; Torriani, Stefano F. F.; Monteux, Sylvain; Sauro, Francesco; De Waele, Jo; Tavagna, Maria Luisa; D'Angeli, Ilenia M.; Chailloux, Daniel; Renda, Michel; Eglinton, Timothy I.; Bontognali, Tomaso R. R.

SCIENTIFIC REPORTS; OCT 29 2015, 5 p15525 10p.

Arisci, Annalisa; De Waele, Jo; Di Gregorio, Felice; Ferrucci, Ivan; Follesa, Roberto

Journal of Coastal Research; Fall2003, Vol. 19 Issue 4, p963-970, 8p, 7 Black and White Photographs, 2 Charts, 2 Maps

instname:Universidad del Rosario; reponame:Repositorio Institucional EdocUR; Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, et al. First detection of the plasmid-mediated class a carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother. 2006 Aug 1;50(8):2880–2.; Bassetti M, Giacobbe DR, Giamarellou H, Viscoli C, Daikos GL, Dimopoulos G, et al. Management of KPC-producing Klebsiella pneumoniae infections. Clinical Microbiology and Infection. 2017 Feb;133–44; Watkins RR, Bonomo RA. Overview: Global and Local Impact of Antibiotic Resistance. Vol. 30, Infectious Disease Clinics of North America. 2016. p. 313–22.; Ocampo A, Vargas C, Sierra P, Biomédica AC-, 2015 undefined. Caracterización molecular de un brote de Klebsiella pneumoniae resistente a carbapenémicos en un hospital de alto nivel de complejidad de Medellín. redalyc.org; Fernández-Canigia L, Dowzicky MJ. Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010. Ann Clin Microbiol Antimicrob. 2012 Oct 22;11(1):29; Park R, O’Brien TF, Huang SS, Baker MA, Yokoe DS, Kulldorff M, et al. Statistical detection of geographic clusters of resistant Escherichia coli in a regional network with WHONET and SaTScan. Expert Rev Anti Infect Ther. 2016 Nov 6;14(11):1097–107.; Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med. 2012 Jun;27(2):128–42.; Lopez JA, Correa A, Navon-Venezia S, Correa AL, Torres JA, Briceño DF, et al. Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. Clin Microbiol Infect. 2011 Jan;17(1):52–6; Costerton JW. The structure and function of the cell envelope of gram-negative bacteria. Rev Can Biol. 1970 Sep;29(3):299–316; Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med. 2005 Jun 27;165(12):1430–5.; Ambler RP. The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci. 1980 May 16;289(1036):321–31; Rodloff AC, Goldstein EJC, Torres A. Two decades of imipenem therapy. J Antimicrob Chemother. 2006 Sep 6;58(5):916–29; Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella 53 pneumoniae. Antimicrob Agents Chemother. 2001 Apr 1;45(4):1151–61.; Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP, et al. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother. 2007 Apr 1;51(4):1553–5.; Heitman M.D., Ph.D. J. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Mycopathologia. 2000;149(1):47–8.; Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013 Sep;13(9):785–96.; Mathers AJ, Carroll J, Sifri CD, Hazen KC. Modified Hodge test versus indirect carbapenemase test: prospective evaluation of a phenotypic assay for detection of Klebsiella pneumoniae carbapenemase (KPC) in Enterobacteriaceae. J Clin Microbiol. 2013 Apr 1;51(4):1291–3.; Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, et al. Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae. J Clin Microbiol. 2007 Aug 1;45(8):2723–5; Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother. 2010 Jun;65(6):1119–25.; Rapp RP, Urban C. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns. Pharmacotherapy. 2012 May;32(5):399–407.; Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011 Dec;17(12):1798–803.; Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009 Dec 2;30(12):1180–5.; Tumbarello M, Trecarichi EM, Tumietto F, Del Bono V, De Rosa FG, Bassetti M, et al. Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2014 Jun;58(6):3514–20.; Papadimitriou-Olivgeris M, Marangos M, Christofidou M, Fligou F, Bartzavali C, Panteli ES, et al. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit. Scand J Infect Dis. 2014 Sep 14;46(9):642–8; Camargo JF, Tobón GJ, Fonseca N, Diaz JL, Uribe M, Molina F, et al. Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus. 2005 Apr 2;14(4):315–20.; Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Sklavou C, Vamvakopoulou S, et al. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis. 2013 Oct;77(2):169–73.; Falcone M, Russo A, Iacovelli A, Restuccia G, Ceccarelli G, Giordano A, et al. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin Microbiol Infect. 2016 May;22(5):444–50.; Fraenkel-Wandel Y, Raveh-Brawer D, Wiener-Well Y, Yinnon AM, Assous M V. Mortality due to bla KPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother. 2016 Apr;71(4):1083–7.; Papadimitriou-Olivgeris M, Fligou F, Bartzavali C, Zotou A, Spyropoulou A, Koutsileou K, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality. Eur J Clin Microbiol Infect Dis. 2017 Jul 19;36(7):1125–31.; da Silva KE, Maciel WG, Sacchi FPC, Carvalhaes CG, Rodrigues-Costa F, da Silva ACR, et al. Risk factors for KPC-producing Klebsiella pneumoniae: watch out for surgery. J Med Microbiol. 2016 Jun 1;65(6):547–53.; Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B, et al. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network. Antimicrob Agents Chemother. 2018 Feb 4;62(2):e01882-17.; Yoon E-J, Kim JO, Kim D, Lee H, Yang JW, Lee KJ, et al. Klebsiella pneumoniaeCarbapenemase Producers in South Korea between 2013 and 2015. Front Microbiol. 2018 Jan 25;9:56.; De Waele JJ, Akova M, Antonelli M, Canton R, Carlet J, De Backer D, et al. Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance. Intensive Care Med. 2018 Feb;44(2):189–96.; Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015 Jul;70(7):2133–43.; León AL, Hoyos NA, Barrera LI, De La Rosa G, Dennis R, Dueñas C, et al. Clinical course of sepsis, severe sepsis, and septic shock in a cohort of infected patients from ten Colombian hospitals. BMC Infect Dis. 2013 Jul 24;13(1):345.; Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012 Dec;12(12):919–24.

Parise, Mario; De Waele, Jo; Gutierrez, Francisco

Engineering Geology. Jun2008, Vol. 99 Issue 3/4, p91-94. 4p.